News

Ossianix presents at PEGS Europe 2016

Ossianix presents a poster “Combined in vivo/in vitro methods for selecting VNARs that shuttle large molecules across the blood brain barrier” and a talk “Delivery of CD20 (Rituximab)-Transferrin Receptor VNAR Bispecific Antibody to the Brain for Treatment of MS and Brain Cancer” at the Protein and Antibody Engineering Summit Europe 2016 in Lisbon. You can download poster here.

Read more

Ossianix publishes a research article

We published a research article in Molecular Immunology. Highlights: VNARs to BAFF with low nM potency were isolated from a semi-synthetic phage library. The CDR3 regions contain a conserved DXL motif found in all three BAFF receptors. VNARs to BAFF block B cell proliferation in response to either human or mouse BAFF. A chimeric VNAR-Fc fusion protein inhibited splenic B cell development in mice. To read more access it online here.…

Read more